Non-Interventional Study
OtherNon-interventional study
NCT Number: NCT04053647
Persistent hypoparathyroidism is an underestimate but major complication of total thyroidectomy. The hypothesis of the investigators is that the mental health is impaired in hypoparathyroid patients compared with thyroidectomized patients without hypoparathyroidism. The investigators evaluated the quality of life using the SF-36 survey in comparison with a control population of patients thyroidectomized but free from this complication. The voice quality, the cardiovascular risk, the kidney function and the incidence of urinary lithiasis were also evaluated.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
CHU Angers, Angers, France
Persistent hypoparathyroidism is an underestimate but major complication of total thyroidectomy. In this retrospective, observational, multicentre study, the investigators evaluated the quality of life using the SF-36 survey in comparison with a control population of patients thyroidectomized but free from this complication. Patients in six centers in France (Angers, Le Mans, Limoges, Nancy, Nantes, la Pitié-Salpétrière) and in the association "Hypoparathyroïdisme France" were contacted by mail. The primary endpoint was the mental health. The physic and global quality of life scores were assessed as secondary endpoints. Medical and VHI surveys were also send to the patients. The voice quality, the cardiovascular risk, the kidney function and the incidence of urinary lithiasis were also evaluated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Non-interventional study
Time frame: Through study completion, an average of 1 year
Items from mental quality of life score defined by the SF36 (Short Form 36) survey
Time frame: Through study completion, an average of 1 year
Items from the SF36 (Short Form 36) survey
Time frame: Through study completion, an average of 1 year
Items from the SF36 (Short Form 36) survey
Time frame: Through study completion, an average of 1 year
Items from the VHI (Voice Handicap Index) survey
Time frame: Through study completion, an average of 1 year
Serum creatinine and clearance dosage
Time frame: Through study completion, an average of 1 year
Serum creatinine and clearance dosage
Time frame: Through study completion, an average of 1 year
Defined as ischemic cardiopathy
Nantes University Hospital
Other
Quality of Life Evaluation (SF-36) in Patients With Permanent Hypoparathyroidism After Total Thyroidectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01922440
Endocrine System Diseases, Hypoparathyroidism
Birmingham, Alabama, United States
View Trial DetailsNCT04701203
Endocrine System Diseases, Hypoparathyroidism
San Francisco, California, United States
View Trial DetailsNCT02924532
Endocrine System Diseases, Hypoparathyroidism
Nîmes, Gard, France
View Trial DetailsNCT04009291
Endocrine System Diseases, Hypoparathyroidism
Chicago, Illinois, United States
View Trial Details